Cargando…
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening
Despite the great success of the administered vaccines against SARS-CoV-2, the virus can still spread, as evidenced by the current circulation of the highly contagious Omicron variant. This emphasizes the additional need to develop effective antiviral countermeasures. In the context of early preclin...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113983/ https://www.ncbi.nlm.nih.gov/pubmed/35595082 http://dx.doi.org/10.1016/j.antiviral.2022.105342 |